Delivery Order SPE2DB24D2205-SPE2DB25FEGZD
- Not listed
- The Defense Logistics Agency awarded a $10,757.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. The order is scheduled for completion by September 22, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under an existing contract vehicle and does not utilize a set-aside...
- The Defense Logistics Agency awarded a $2,495.69 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Menveo vaccine (1 vial A-C-Y-W-135-DIP 0.5ML), with completion scheduled for June 20, 2025. This competitive award carries no set-aside designation and utilizes firm fixed pricing under a delivery order contract type. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $8,177.53 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal vaccine. The contract is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a competitive procurement with no set-aside designation and falls under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a ceiling value of $18,340.29. This firm fixed-price delivery order, which must be completed by September 16, 2025, was awarded competitively with no set-aside designation. The award was issued from Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine products, with a ceiling value of $119,112.76. This firm fixed-price delivery order is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $33,098.70 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine products, with a completion date of May 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGZDDelivery Order
The Defense Logistics Agency awarded a $36,955.80 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML vaccines. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under a larger indefinite delivery vehicle. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and medical commodities across multiple therapeutic domains. The prime contract facilitates support to various government healthcare customers, including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor within the federal medical procurement supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.0k | 9/2/25 |